Nanoform’s Clinical Study Indicates Positive Interim Results
25/02/2021
Helsinki, Finland – Nanoform Finland Plc (“Nanoform”), an innovative nanoparticle medicine enabling company, today announc…
25/02/2021
21/01/2021
18/01/2021
16/12/2020
18/02/2020
06/02/2020